Benzinga | Aug 7, 2020 06:36AM EDT

Needham Maintains Buy on GW Pharmaceuticals, Lowers Price Target to $180

Needham analyst Serge Belanger maintains GW Pharmaceuticals (NASDAQ:GWPH) with a Buy and lowers the price target from $190 to $180.